Regulating Producers

"Regulating producers" generally refers to the laws and regulations that govern insurance producers, also known as insurance agents or brokers. Insurance producers are licensed professionals who help individuals and businesses navigate the insurance market and purchase insurance policies that meet their needs.

The regulation of insurance producers varies by state, but there are some common features across the United States. Key features of regulating producers include:

  • Licensing requirements: To become an insurance producer, an individual must typically pass a licensing exam and meet other requirements, such as completing pre-licensing education and passing a background check.

  • Continuing education: Many states require insurance producers to complete a certain number of hours of continuing education each year in order to maintain their license.

  • Ethical standards: Insurance producers are held to ethical standards that require them to act in the best interests of their clients and avoid conflicts of interest.

  • Disclosure requirements: Insurance producers are required to disclose certain information to their clients, such as their commission rates and any conflicts of interest that may arise.

  • Enforcement mechanisms: State insurance departments have the authority to investigate and discipline insurance producers who violate licensing or ethical standards.

The regulation of insurance producers can impact employee benefits in several ways. For example, it can help ensure that employees receive accurate information about their benefits options and that insurance producers are acting in the employees' best interests. It can also provide a mechanism for resolving disputes between employees and insurance producers or insurers.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.